Independent Pharmacy Lobby’s Agenda Could Undermine Fraud Detection Efforts
WASHINGTON--(BUSINESS WIRE)-- The Medicare fraud caused by independent “phantom pharmacies” highlights the need to resist the independent pharmacy lobby’s efforts to dismantle programs that fight fraud, waste, and abuse, the Pharmaceutical Care Management Association (PCMA) said in letters sent to Senate Finance Committee Ranking Member Charles Grassley (R-Iowa) and Health and Human Services (HHS) Secretary Kathleen Sebelius.
PCMA is the national association representing America’s pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 210 million Americans with health coverage provided through Fortune 500 employers, health insurers, labor unions, and Medicare. PBMs and Medicare Part D plans employ a variety of state-of-the-art techniques when working with pharmacies and other stakeholders to combat fraud, waste, and abuse. The federal government states that a staggering $60 billion is stolen from taxpayers through Medicare scams every year.
“Given the size of the deficit, we can’t afford to let anyone, including the independent pharmacy lobby, thwart congressional efforts to fight pharmacy fraud,” said PCMA President and CEO Mark Merritt.
In the letters to Senator Grassley and Secretary Sebelius, PCMA outlines several proposals being pushed by the independent pharmacy lobby that could make it more difficult to root out fraud, waste, and abuse:
PCMA represents the nation’s pharmacy benefit managers (PBMs), which improve affordability and quality of care through the use of electronic prescribing (e-prescribing), generic alternatives, mail-service pharmacies, and other innovative tools for 210-plus million Americans.
Charles Coté, 202-207-3605
KEYWORDS: United States North America District of Columbia
INDUSTRY KEYWORDS: Health Public Policy/Government Healthcare Reform Congressional News/Views Pharmaceutical Public Policy White House/Federal Government General Health Managed Care